Javascript must be enabled to continue!
Diagnostic Accuracy of SARS-CoV-2 Rapid Antigen Test (Oral Fluid) with Unsupervised Self-sampling in the Omicron Period
View through CrossRef
Background: To assess the performance of rapid antigen tests between unsupervised oral fluid self-sampling and nasal self-sampling during the omicron period. Objective: To diagnostically validate SARS-CoV-2 Rapid Antigen Test (Oral Fluid) by comparing results with those of nasal self-sampling in the omicron period. Method: Run rapid in vitro diagnostic tests for detection of antigen to SARS-CoV-2 in nasal and oral fluid sampling, compared to a leading commercial test using clinical specimens for validation of performance. Result: When nasal self-sampling compared with nasal self-sampling, sensitivities were found to be slightly higher in confirmatory testers. Sensitivity (94.3%): In total 297 PCR in the Clinitest group were confirmatory testers (previously tested positive by a self-test at own initiative), 280 PCR confirmed positive samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid). 17 false negative cases were reported. Specificity (99.4%): In total 350 PCR confirmed negative samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid). Only 2 false positive cases were reported.Accuracy (97.1%): In total 649 PCR confirmed samples: 630 PCR confirmed samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid). Among which, overall sensitivities with nasal self-sampling were 79.0% (95% confidence interval 74.7% to 82.8%) for SARS-CoV-2 by Rapid Antigen Tests on Saliva. Sensitivities were substantially higher in confirmatory testers with Citest SARS-CoV-2 Rapid Antigen Test (Oral Fluid) than in those who tested for other reasons.Conclusion: Sensitivities of three rapid antigen tests with nasal self-sampling decreased during the emergence of omicron but was only statistically significant for Clinitest. Sensitivities appeared to be substantially influenced by the proportion of confirmatory testers. Sensitivities of Citest SARS-CoV-2 Rapid Antigen Test improved after the addition of Oral Fluid self-sampling. A positive self-test result justifies prompt self-isolation without the need for confirmatory testing. Individuals with a negative self-test result should adhere to general preventive measures because a false negative result cannot be ruled out.
Title: Diagnostic Accuracy of SARS-CoV-2 Rapid Antigen Test (Oral Fluid) with Unsupervised Self-sampling in the Omicron Period
Description:
Background: To assess the performance of rapid antigen tests between unsupervised oral fluid self-sampling and nasal self-sampling during the omicron period.
Objective: To diagnostically validate SARS-CoV-2 Rapid Antigen Test (Oral Fluid) by comparing results with those of nasal self-sampling in the omicron period.
Method: Run rapid in vitro diagnostic tests for detection of antigen to SARS-CoV-2 in nasal and oral fluid sampling, compared to a leading commercial test using clinical specimens for validation of performance.
Result: When nasal self-sampling compared with nasal self-sampling, sensitivities were found to be slightly higher in confirmatory testers.
Sensitivity (94.
3%): In total 297 PCR in the Clinitest group were confirmatory testers (previously tested positive by a self-test at own initiative), 280 PCR confirmed positive samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid).
17 false negative cases were reported.
Specificity (99.
4%): In total 350 PCR confirmed negative samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid).
Only 2 false positive cases were reported.
Accuracy (97.
1%): In total 649 PCR confirmed samples: 630 PCR confirmed samples were correctly detected by SARS-CoV-2 (COVID-19) Rapid Test (Oral Fluid).
Among which, overall sensitivities with nasal self-sampling were 79.
0% (95% confidence interval 74.
7% to 82.
8%) for SARS-CoV-2 by Rapid Antigen Tests on Saliva.
Sensitivities were substantially higher in confirmatory testers with Citest SARS-CoV-2 Rapid Antigen Test (Oral Fluid) than in those who tested for other reasons.
Conclusion: Sensitivities of three rapid antigen tests with nasal self-sampling decreased during the emergence of omicron but was only statistically significant for Clinitest.
Sensitivities appeared to be substantially influenced by the proportion of confirmatory testers.
Sensitivities of Citest SARS-CoV-2 Rapid Antigen Test improved after the addition of Oral Fluid self-sampling.
A positive self-test result justifies prompt self-isolation without the need for confirmatory testing.
Individuals with a negative self-test result should adhere to general preventive measures because a false negative result cannot be ruled out.
Related Results
L᾽«unilinguisme» officiel de Constantinople byzantine (VIIe-XIIe s.)
L᾽«unilinguisme» officiel de Constantinople byzantine (VIIe-XIIe s.)
<p>Νίκος Οικονομίδης</...
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Un manoscritto equivocato del copista santo Theophilos († 1548)
Un manoscritto equivocato del copista santo Theophilos († 1548)
<p><font size="3"><span class="A1"><span style="font-family: 'Times New Roman','serif'">ΕΝΑ ΛΑΝ&...
Antigen evolution from D614, to G614, to Delta, and to Omicron subtype of SARS-CoV-2
Antigen evolution from D614, to G614, to Delta, and to Omicron subtype of SARS-CoV-2
Abstract
Importance: Since 2019, the antigens from Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) are keeping in evolution from initial D614, to G614, to Del...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
A survey and antibody test following the surge of SARS-CoV-2 Omicron infection in China
A survey and antibody test following the surge of SARS-CoV-2 Omicron infection in China
AbstractThe surge of SARS-CoV-2 Omicron infection in most Chinese residents at the end of 2022 provided a unique opportunity to understand how the immune system responds to the Omi...

